American Healthcare Reit Inc 's Revenue in the fiscal year 2025 $ 2,260.12 millions
American Healthcare Reit Inc 's Revenue in the fiscal year 2024 $ 2,070.67 millions
American Healthcare Reit Inc 's Revenue in the fiscal year 2023 $ 3,725.76 millions
American Healthcare Reit Inc 's Revenue in the fiscal year 2022 $ 3,260.68 millions
American Healthcare Reit Inc 's Revenue in the fiscal year 2021 $ 2,547.56 millions
AHR Revenue third quarter 2026 Y/Y Growth Comment
American Healthcare Reit Inc reported Revenue improvement of 29.53% year on year in the third quarter 2026, to $ 742.15 millions, this is lower than American Healthcare Reit Inc 's recent average Revenue surge of 240.33%.
Looking into third quarter 2026 results within Real Estate Investment Trusts industry 98 other companies have achieved higher Revenue growth. While American Healthcare Reit Inc ' s Revenue rise of 29.53% ranks overall at the positon no. 2277 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
American Healthcare Reit Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
1348.21 %
95.42 %
-74.98 %
(Dec 31 2021)
AHR's III. Quarter Q/Q Revenue Comment
American Healthcare Reit Inc achieved in the III. Quarter 2026 below company average Revenue rise of 10.07% quarter on quarter, to $ 742.15 millions.
III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 5.61% in the III. Quarter a year ago.
Within Real Estate Investment Trusts industry 51 other companies have achieved higher Revenue quarter on quarter growth. While American Healthcare Reit Inc 's Revenue growth quarter on quarter, overall rank is 1282.
American Healthcare Reit Inc achieved in the III. Quarter 2026 below company average Revenue rise of 10.07% quarter on quarter, to $ 742.15 millions.
III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 5.61% in the III. Quarter a year ago.
Within Real Estate Investment Trusts industry 51 other companies have achieved higher Revenue quarter on quarter growth. While American Healthcare Reit Inc 's Revenue growth quarter on quarter, overall rank is 1282.
American Healthcare Reit Inc 's 12 Months Revenue Growth Year on Year
Although American Healthcare Reit Inc 's Annual Revenue growth year on year were below company's average 240.33% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 16.39% year on year, from 12.24% in Mar 31 2026.
In the Financial sector 317 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 649 to 1251.
Although American Healthcare Reit Inc 's Annual Revenue growth year on year were below company's average 240.33% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 16.39% year on year, from 12.24% in Mar 31 2026.
In the Financial sector 317 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 649 to 1251.
About American Healthcare Reit Inc Revenue Growth Rates (AHR), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
What’s included here
Company: American Healthcare Reit Inc
(CIK 1632970).
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.